124 related articles for article (PubMed ID: 23852836)
1. Self-assemblies of pH-activatable PEGylated multiarm poly(lactic acid-co-glycolic acid)-doxorubicin prodrugs with improved long-term antitumor efficacies.
Ding J; Li D; Zhuang X; Chen X
Macromol Biosci; 2013 Oct; 13(10):1300-7. PubMed ID: 23852836
[TBL] [Abstract][Full Text] [Related]
2. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
4. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin.
Lee H; Ahn CH; Park TG
Macromol Biosci; 2009 Apr; 9(4):336-42. PubMed ID: 19006195
[TBL] [Abstract][Full Text] [Related]
5. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
[TBL] [Abstract][Full Text] [Related]
6. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.
Jin C; Qian N; Zhao W; Yang W; Bai L; Wu H; Wang M; Song W; Dou K
Biomacromolecules; 2010 Sep; 11(9):2422-31. PubMed ID: 20831277
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-triggered drug release and enhanced anticancer effect of doxorubicin-loaded poly(D,L-lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanodroplets.
Du L; Jin Y; Zhou W; Zhao J
Ultrasound Med Biol; 2011 Aug; 37(8):1252-8. PubMed ID: 21683513
[TBL] [Abstract][Full Text] [Related]
8. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
9. A macromolecular prodrug strategy for combinatorial drug delivery.
Li NN; Lin J; Gao D; Zhang LM
J Colloid Interface Sci; 2014 Mar; 417():301-9. PubMed ID: 24407691
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of antitumor activity of acid-sensitive PEGylated doxorubicin.
Sun D; Ding J; Xiao C; Chen J; Zhuang X; Chen X
ACS Appl Mater Interfaces; 2014 Dec; 6(23):21202-14. PubMed ID: 25415351
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
Lee ES; Na K; Bae YH
J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
[TBL] [Abstract][Full Text] [Related]
12. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
13. Specific targeting of A54 homing peptide-functionalized dextran-g-poly(lactic-co-glycolic acid) micelles to tumor cells.
Situ JQ; Ye YQ; Zhu XL; Yu RS; You J; Yuan H; Hu FQ; Du YZ
Int J Nanomedicine; 2015; 10():665-75. PubMed ID: 25653517
[TBL] [Abstract][Full Text] [Related]
14. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
15. Polymeric topology and composition constrained polyether-polyester micelles for directional antitumor drug delivery.
Li D; Sun H; Ding J; Tang Z; Zhang Y; Xu W; Zhuang X; Chen X
Acta Biomater; 2013 Nov; 9(11):8875-84. PubMed ID: 23831719
[TBL] [Abstract][Full Text] [Related]
16. pH-Responsive Reversible PEGylation Improves Performance of Antineoplastic Agent.
Sun D; Ding J; Xiao C; Chen J; Zhuang X; Chen X
Adv Healthc Mater; 2015 Apr; 4(6):844-55. PubMed ID: 25645303
[TBL] [Abstract][Full Text] [Related]
17. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M
Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363
[TBL] [Abstract][Full Text] [Related]
18. Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice.
Zhou L; Cheng R; Tao H; Ma S; Guo W; Meng F; Liu H; Liu Z; Zhong Z
Biomacromolecules; 2011 May; 12(5):1460-7. PubMed ID: 21332185
[TBL] [Abstract][Full Text] [Related]
19. Amphiphilic polycarbonate conjugates of doxorubicin with pH-sensitive hydrazone linker for controlled release.
Jiang T; Li YM; Lv Y; Cheng YJ; He F; Zhuo RX
Colloids Surf B Biointerfaces; 2013 Nov; 111():542-8. PubMed ID: 23893028
[TBL] [Abstract][Full Text] [Related]
20. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy.
Hu FQ; Zhang YY; You J; Yuan H; Du YZ
Mol Pharm; 2012 Sep; 9(9):2469-78. PubMed ID: 22827551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
